Companies / Alterity Therapeutics Ltd

Alterity Therapeutics Ltd

Nasdaq: ATHECIK 1131343MELBOURNE

Ownership

9.13B shares outstanding
0.00%Institutions
Ownership
Institutions<0.01%324,761
Public float100.00%9,127,045,925

% of common shares outstanding (single-class filing figure). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 6

View all โ†’
Insider% of sharesShares
Babarczy Julian MichaelDirector
โ€”โ€”
Cunningham Ann MichelleDirector
โ€”โ€”
Gozlan Lawrence BernardDirector
โ€”โ€”
Macnish Niven Abby SarahChief Financial Officer
โ€”โ€”
Marks Peter AshleyDirector
โ€”โ€”
Stamler David AllenCEOChief Executive Officer ยท Director
โ€”โ€”

Institutional holders 17

View all โ†’
HolderValue% of shares
Twin Lakes Capital Management, LLC$428.9K<0.01%
Morgan Stanley$196.1K<0.01%
HB Wealth Management, LLC$180.1K<0.01%
Greenleaf Trust$111.4K<0.01%
Citadel Advisors LLC$51.8K<0.01%
BNP Paribas Financial Markets$23.7K<0.01%
Rhumbline Advisers$7.0K<0.01%
GAMMA Investing LLC$2.4K<0.01%
Osaic Holdings, Inc.$247<0.01%
Blue Trust, Inc.$123<0.01%

Activity

Mar 31, 2026View all โ†’
InsidersInstitutions
Who's accumulating and trimming this stock (13F).
DateActorActionSecurityValueShares ฮ”Position afterImpact
Q1 2026
as of
Rhumbline Advisers
13F manager
TrimADR$-559-157
-7.38%
1,970
<0.01% of shares
low
Q1 2026
as of
BNP Paribas Financial Markets
13F manager
TrimADR$-348-100
-1.45%
6,809
<0.01% of shares
low
Q3 2024
as of
Danske Bank A/S
13F manager
NewADR$1+1
1
0.00% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ATHEADREquity02155X205BBG000DK9TP0